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Abstract In this study, we investigate the accuracy of two
consecutive ulcer cultures with bone contact compared to
bone biopsy for the diagnosis of diabetic toe osteomyelitis.
The same nurse and orthopaedic surgeon obtained all
samples: sample A-1: bone contact swabbing through the
ulcer; sample A-2: a second culture swabbing from the
bone surface within 24 h; sample B: surgical bone biopsy in
the operating theatre. The kappa statistic measure between
samples A-1 and A-2 (bone contact swabs) indicated
82.35% agreement. The sensitivity, specificity, positive
and negative predictive values of the two samples A
compared to B were 96%, 79%, 92% and 88%, respec-
tively, for the causative pathogen. These results were
similar with prior antibiotic treatment, discordant bone
surface swabs or with monomicrobial infections. As a
conclusion, two consecutive diabetic toe cultures with
bone contact accurately predict the pathogen of diabetic
toe osteomyelitis in 90% of cases.
Pathogen identification and antibiotic susceptibility testing
are important to provide appropriate antibiotic therapy for
chronic infectious osteomyelitis [1]. Bone cultures (with
histological confirmation) represent the gold standard for its
diagnosis [1, 2], but usually require a surgical biopsy,
which is resource-consuming, anaesthesia-demanding and
associated with a non-negligible potential for adverse
events [1–3].
Diabetic toe osteomyelitis is a different clinical entity. In
contrast to chronic osteomyelitis of long bones [1, 4],
infected toes are difficult to sample. Orthopaedic surgeons
often are reluctant to perform a toe biopsy in an immune-
suppressed patient, compromised by arterial insufficiency,
ulcers and neuropathic osteopathy.
Superficial wound swabbing has been proven inadequate
for predicting the infecting microorganisms [1, 2]. However,
several studies investigated the accuracy of consecutive deep
sinus tract cultures compared to bone biopsy [3–9]. In cases
of monomicrobial osteomyelitis with sinus tract, concordant
tract cultures with bone contact accurately predicted the
pathogen of bone cultures [3, 6–8], which, however, was not
unanimously confirmed [4, 5, 9]. Many of these studies did
not include patients with diabetic toe osteomyelitis [4, 9],
nor did they stratify patients between long bone and diabetic
foot infection [3].
We performed a prospective study at the Orthopaedic
Surgery Service of the Geneva University Hospitals to
assess the accuracy of two deep consecutive ulcer cultures
with bone contact in the identification of the pathogen of
underlying osteomyelitis [3]. During a three-year-period, all
adult patients with diabetic toe osteomyelitis with bone
contact were enrolled in a non-randomised protocol.
Osteomyelitis was confirmed by histological, radiological
(magnetic resonance imaging [MRI] or standard X-rays)
and/or microbiological specimens from a surgical bone
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biopsy. Exclusion criteria were implant-related infections,
absence of surgery for cure or patient refusal. Approval
from the Ethical Committee was waived, since it was an
internal quality assessment project.
The same nurse and orthopaedic surgeon obtained all
samples: sample A-1: bone contact swabbing through the
ulcer; sample A-2: a second culture swabbing from the bone
surface at the same localisation as A-1; sample B: surgical
bone biopsy in the operating theatre through a clinically
uninfected area outside of the ulcer, from a distance of 2 to
4 cm. For samples A-1 and A-2, sterile cotton swabs were
inserted until contact with the bone that was swabbed. The
time interval between samples A and B was 24 h at the most.
The microbiological specimens were transported to the
laboratory within 30 min and quantitatively cultured with
standard aerobic and anaerobic methods [10] over 5 days.
According to the study definitions, the dominant pathogen
required at least a three times higher growth in bone cultures
than other microorganisms.
A total of 68 patients with diabetic toe osteomyelitis
participated in the study (median age 70 years). All
infections were secondary to a pre-existing ulcer. In 39
episodes (57%), the patients were already on antibiotic
therapy for a median of 9 days (range 1 to 30 days). Sample
B specimens yielded 22 polymicrobial infections (32%,
range 1–3 pathogens). The dominant pathogens were:
Staphylococcus aureus (n=18; three methicillin-resistant),
Streptococcus sp. (n=8), Enterobacteriaceae (n=10), Pseu-
domonas aeruginosa (n=6), other non-fermenting Gram-
negative rods (n=5), other aerobic (n=9) and anaerobic
bacteria (n=1). In 20 episodes (29%), there was no growth,
of which 17 cases were due to preceding antibiotic
treatment. The non-dominant pathogens were mostly
coagulase-negative staphylococci, Corynebacteria or Sten-
otrophomonas maltophilia.
Sample B (bone biopsy) was the gold standard. The
unweighted kappa statistic measure between samples A-1
and A-2 (bone contact swabs) indicated 82.35% agreement.
The sensitivity, specificity, positive and negative predictive
values of the two samples A compared to B were 96%,
79%, 92% and 88% for the dominant pathogen (Table 1).
These results were similar for the patient strata with prior
antibiotic treatment, discordant bone swabs on the bone
surface or with monomicrobial infections (Table 1). In
seven cases (10%), samples A yielded additional pathogens
that were not confirmed in sample B. Regarding the exact
number and identification of all pathogens (independently
of dominant or non-dominant microorganisms), the sensi-
tivity, specificity, positive and negative predictive values
were 90%, 58%, 78% and 79%, respectively.
We conclude that two consecutive diabetic toe cultures
with bone contact accurately predict the dominant pathogen in
greater than 90% of cases, independently of discordant bone
swabs samples or prior antibiotic treatment. The sensitivity is
always better than the specificity. Our findings are congruent
with prior results regarding chronic osteomyelitis non-related
to diabetic foot infection (91% sensitivity and 86% specificity
of samples A compared to B) [3] or with the recent literature
of this topic [11]. However, there is also conflicting results
reported by Senneville et al. revealing a poor reliability in
identifying bone bacteria through ulcer swab cultures, with
concordance between bone biopsy specimens and superficial
ulcer swabs oscillating between 22.5 and 42.8% depending
upon the pathogen investigated [12]. However, their pro-
spective trial showed some differences from ours that might
explain the differences. We performed two consecutive
samples from the bone surface, whereas in Senneville et
al.’s study, one single sample was performed from the ulcer.
Their protocol did not grant a bone contact per se. We
sampled toe osteomyelitis (phalanx), while in Senneville et
al.’s study, at least 40% of all specimens were sampled from
the metatarsal bone. Bone samples were taken in the
operating theatre in our study compared to sampling on the
ward in Senneville et al.’s study. Moreover, their bone
Table 1 Comparison of two consecutive bone contact swabbings through an ulcer in the predilection of the pathogen of diabetic toe osteomyelitis
(gold standard: bone biopsy)
Sample No. of
samples




All A-1 and A-2 samples 68 96% 79% 92% 88%
A-1 and A-2 concordant 56 95% 100% 100% 88%
A-1 and A-2 with prior antibiotic
treatment
39 95% 82% 88% 93%
A-1 and A-2 in monomicrobial
infections
46 96% 79% 94% 87%
Sample A-1: deep ulcer culture with bone contact
Sample A-2: second deep ulcer tract culture at a different time but at the same localisation as A-1
Sample B: surgical bone biopsy through a clinically uninfected area
Concordant: same microbiological result of samples A-1 and A-2
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biopsies yielded a significant higher proportion (25.6%) of
coagulase-negative staphylococci as the only pathogen [12],
whereas in our study with quantitative cultures, coagulase-
negative staphylococci were considered as commensals,
since their quantification was inferior to other concomitant
and more classical pathogens of osteomyelitis, such as S.
aureus or P. aeruginosa.
Our good results concern the prediction of pathogens
that dominate the bone cultures and constitute the classic
bacteria of osteomyelitis [1]. The described method is less
useful when it comes to the identification of non-dominant
pathogens usually interpreted as commensals of superficial
swabs. In our opinion, our alternative diagnostic method
might be sufficient in situations where bone biopsy is
difficult or amputation is refused [1]. In reality, this
situation would likely concern only a minority of cases. In
no way should deep ulcer specimens from the bone surface
should replace bone cultures in situations where biopsy can
be readily obtained, because bone cultures together with
histology remain the gold standard for the diagnosis of
osteomyelitis [1–9, 11]. Further trials are needed to confirm
our findings.
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